Genelux (GNLX) Shares Outstanding (2022 - 2026)
Genelux (GNLX) recorded quarterly Shares Outstanding of $44.8 million in Q1 2026, up 17.57% quarter-over-quarter from $38.1 million in Q4 2025, and up 18.84% on a YoY basis from $37.7 million in Q1 2025.
Genelux (GNLX) Shares Outstanding (2022 - 2026) Analysis & Trends
Genelux's Shares Outstanding history runs 5 years deep, the most recent figure standing at $44.8 million for Q1 2026.
- In Q1 2026, Shares Outstanding rose 18.84% year-over-year to $44.8 million; the TTM figure through Mar 2026 stood at $44.8 million (up 18.84% YoY), while the FY2025 annual figure was $38.1 million, up 9.82% from the prior year.
- Shares Outstanding was $44.8 million for Q1 2026 at Genelux, up from $38.1 million in the prior quarter.
- In the past five years, Shares Outstanding ranged from a high of $44.8 million in Q1 2026 to a low of -$433333.0 in Q3 2022.
- Historically, Shares Outstanding has averaged $29.7 million across 5 years, with a median of $30.8 million in 2024.
- The sharpest annual moves came in 2023 and 2024: Shares Outstanding changed 0.0% in 2023, then jumped 8070.36% in 2024.
- A 5-year view of Shares Outstanding shows it stood at $22.1 million in 2022, then grew by 21.25% to $26.8 million in 2023, then climbed by 29.64% to $34.7 million in 2024, then rose by 9.82% to $38.1 million in 2025, then increased by 17.57% to $44.8 million in 2026.
- The last three Shares Outstanding figures came in at $44.8 million (Q1 2026), $38.1 million (Q4 2025), and $38.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 40.14 Bn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 91.57 Bn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 254.16 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Genelux | 129.36 Mn | 129.36 Mn | - | 44.84 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 44.84 Mn |
| Mar 31, 2026 | 44.84 Mn |
| Mar 31, 2026 | 44.84 Mn |
| Mar 31, 2026 | 44.84 Mn |
| Mar 31, 2026 | 44.84 Mn |
| Mar 31, 2026 | 44.84 Mn |
| Mar 31, 2026 | 44.84 Mn |
| Mar 31, 2026 | 44.84 Mn |
| Dec 31, 2025 | 38.14 Mn |
| Dec 31, 2025 | 38.14 Mn |
| Dec 31, 2025 | 38.14 Mn |
| Dec 31, 2025 | 38.14 Mn |
| Dec 31, 2025 | 38.14 Mn |
| Dec 31, 2025 | 38.14 Mn |
| Dec 31, 2025 | 38.14 Mn |
| Dec 31, 2025 | 38.14 Mn |
| Sep 30, 2025 | 38.05 Mn |
| Sep 30, 2025 | 38.05 Mn |
| Sep 30, 2025 | 38.05 Mn |
| Sep 30, 2025 | 38.05 Mn |